HDAC inhibitors in parasitic diseases

KT Andrews, A Haque, MK Jones - Immunology and cell …, 2012 - Wiley Online Library
Parasitic diseases cause significant global morbidity and mortality, particularly in
underdeveloped regions of the world. Malaria alone causes∼ 800 000 deaths each year …

Targeting histone acetylation/deacetylation in parasites: an update (2017–2020)

R Fioravanti, N Mautone, A Rovere, D Rotili… - Current Opinion in …, 2020 - Elsevier
Histone modifying enzymes have vital roles in the growth and survival of both parasites and
humans. Targeting the epigenome can be a new strategy for the treatment of parasitic …

Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites

A Bougdour, D Maubon, P Baldacci, P Ortet… - Journal of Experimental …, 2009 - rupress.org
Plasmodium and Toxoplasma are parasites of major medical importance that belong to the
Apicomplexa phylum of protozoa. These parasites transform into various stages during their …

[HTML][HTML] Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth

MJ Chua, MSJ Arnold, W Xu, J Lancelot… - International Journal for …, 2017 - Elsevier
Malaria, schistosomiasis and leishmaniases are among the most prevalent tropical parasitic
diseases and each requires new innovative treatments. Targeting essential parasite …

[HTML][HTML] Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites

N Coetzee, H von Grüning, D Opperman… - Scientific reports, 2020 - nature.com
The epigenome of the malaria parasite, Plasmodium falciparum, is associated with
regulation of various essential processes in the parasite including control of proliferation …

Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum

NA Malmquist, TA Moss, S Mecheri… - Proceedings of the …, 2012 - National Acad Sciences
Epigenetic factors such as histone methylation control the developmental progression of
malaria parasites during the complex life cycle in the human host. We investigated …

Lysine deacetylase inhibitors in parasites: past, present, and future perspectives

GS Hailu, D Robaa, M Forgione, W Sippl… - Journal of Medicinal …, 2017 - ACS Publications
Current therapies for human parasite infections rely on a few drugs, most of which have
severe side effects, and their helpfulness is being seriously compromised by the drug …

[HTML][HTML] Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites

JA Engel, AJ Jones, VM Avery… - International Journal for …, 2015 - Elsevier
Histone deacetylase (HDAC) enzymes work together with histone acetyltransferases (HATs)
to reversibly acetylate both histone and non-histone proteins. As a result, these enzymes are …

Identification of novel quinazoline derivatives as potent antiplasmodial agents

A Bouchut, D Rotili, C Pierrot, S Valente… - European Journal of …, 2019 - Elsevier
Despite the recent reductions in the global burden of malaria, this disease remains a
devastating cause of death in tropical and subtropical regions. As there is no broadly …

Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine

P Wipf, T Mo, SJ Geib, D Caridha, GS Dow… - Organic & …, 2009 - pubs.rsc.org
Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine -
Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/B911483A Royal Society …